Abbott Laboratories: Strong Q4 Results And Bullish Outlook
Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...
Yahoo Finance2d
Abbott Laboratories (NYSE:ABT) Posts Q4 Sales In Line With Estimates
Abbott Laboratories (ABT) Q4 CY2024 Highlights: Revenue: $10.97 billion vs analyst estimates of $11.02 billion (7.2% year-on-year growth, in line) Adjusted EPS: $1.34 vs analyst estimates of $1.34 ...
Argus Research Sticks to Their Buy Rating for Abbott Laboratories (ABT)
In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Abbott Laboratories (ABT – Research Report). The ...